administered intraocular injections to 100% of patients and saw infec-
tion rates drop 22-fold. Dr. Shorstein says that's a greater drop than
what's reported in the literature because of the higher than normal
baseline infection rate in 2007.
The ability of patients in general, and the elderly in particular, to con-
sistently and properly administer eye drops is problematic, says Dr.
Shorstein, who adds, "Part of the effectiveness of antibiotic injections
has to do with its route, that it's directly administered by the surgeon."
Added precautions
The risk of bioresidue and denatured viscoelastic substance remaining
on instruments with small lumens could cause infection if bacteria
adhere to the residue that's not killed during the sterilization process,
brought to you by
VISIT US AT AAO BOOTH #5255
Proprietary Sterile Injectable Compounded Formulations
†
S H I F T T H E T R E A T M E N T P A R A D I G M
TRI-MOXI*
TRI-MOXI-VANC**
LYOPHILIZED MYDRIATICS
†
Compounded by a pharmacist pursuant to a prescription to meet the needs
of individual patients. Some patients may need drops.
7ULDPFLQRORQHDFHWRQLGHDQGPR[LÁR[DFLQhydrochloride
7ULDPFLQRORQHDFHWRQLGHPR[LÁR[DFLQK\GURFKORULGHDQG
vancomycin
Learn more at GoDropless.com
©2015 Imprimis Pharmaceuticals, Inc. All Rights Reserved. IMPO0072 09/15
Reduce issues with
patient compliance
Single intraocular
administration
Decrease
overall costs
